{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:26:44Z","timestamp":1772821604769,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1F31HL176054-01"],"award-info":[{"award-number":["1F31HL176054-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL157491-01"],"award-info":[{"award-number":["1R01HL157491-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK124549"],"award-info":[{"award-number":["R01DK124549"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18POST33990231"],"award-info":[{"award-number":["18POST33990231"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Regen Med"],"DOI":"10.1038\/s41536-025-00419-w","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T13:01:16Z","timestamp":1753102876000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Modulating the platelet-mediated innate foreign body response to affect in situ vascular tissue engineering outcomes"],"prefix":"10.1038","volume":"10","author":[{"given":"Mackenzie E.","family":"Turner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingru","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph T.","family":"Leland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delaney J.","family":"Villarreal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahana","family":"Rajesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sugath","family":"Suravarapu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kan N.","family":"Hor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew G.","family":"Wiet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryce A.","family":"Kerlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron A.","family":"Best","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James W.","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher K.","family":"Breuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"419_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.smim.2007.11.004","volume":"20","author":"JM Anderson","year":"2007","unstructured":"Anderson, J. M., Rodriguez, A. & Chang, D. T. Foreign body reaction to biomaterials. Semin. Immunol. 20, 86 (2007).","journal-title":"Semin. Immunol."},{"key":"419_CR2","first-page":"130","volume":"7","author":"JE Mayer Jr","year":"1995","unstructured":"Mayer, J. E. Jr Uses of homograft conduits for right ventricle to pulmonary artery connections in the neonatal period. Semin. Thorac. Cardiovasc. Surg. 7, 130\u2013132 (1995).","journal-title":"Semin. Thorac. Cardiovasc. Surg."},{"key":"419_CR3","doi-asserted-by":"crossref","unstructured":"Blum, K. M. et al. Tissue engineered vascular grafts transform into autologous neovessels capable of native function and growth. Commun. Med. 2, (2022).","DOI":"10.1038\/s43856-021-00063-7"},{"key":"419_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jtcvs.2009.09.057","volume":"139","author":"N Hibino","year":"2010","unstructured":"Hibino, N. et al. Late-term results of tissue-engineered vascular grafts in humans. J. Thorac. Cardiovasc. Surg. 139, 431\u2013436 (2010).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"419_CR5","doi-asserted-by":"publisher","first-page":"eaax6919","DOI":"10.1126\/scitranslmed.aax6919","volume":"12","author":"JD Drews","year":"2020","unstructured":"Drews, J. D. et al. Spontaneous reversal of stenosis in tissue-engineered vascular grafts. Sci. Transl. Med. 12, eaax6919 (2020).","journal-title":"Sci. Transl. Med."},{"key":"419_CR6","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1007\/s10439-018-2086-7","volume":"46","author":"JM Szafron","year":"2018","unstructured":"Szafron, J. M. et al. Immuno-driven and Mechano-mediated Neotissue Formation in Tissue Engineered Vascular Grafts. Ann. Biomed. Eng. 46, 1938\u20131950 (2018).","journal-title":"Ann. Biomed. Eng."},{"key":"419_CR7","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1096\/fj.11-186585","volume":"25","author":"N Hibino","year":"2011","unstructured":"Hibino, N. et al. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts. FASEB J. 25, 4253 (2011).","journal-title":"FASEB J."},{"key":"419_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1089\/ten.tea.2017.0044","volume":"24","author":"T Fukunishi","year":"2018","unstructured":"Fukunishi, T. et al. Role of bone marrow mononuclear cell seeding for nanofiber vascular grafts. Tissue Eng. Part A 24, 135 (2018).","journal-title":"Tissue Eng. Part A"},{"key":"419_CR9","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1021\/acsbiomaterials.6b00123","volume":"3","author":"C Best","year":"2017","unstructured":"Best, C. et al. Deconstructing the tissue engineered vascular graft: evaluating scaffold pre-wetting, conditioned media incubation, and determining the optimal mononuclear cell source. ACS Biomater. Sci. Eng. 3, 1972\u20131979 (2017).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"419_CR10","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1096\/fj.14-268334","volume":"29","author":"N Hibino","year":"2015","unstructured":"Hibino, N. et al. The innate immune system contributes to tissue-engineered vascular graft performance. FASEB J. 29, 2431\u20132438 (2015).","journal-title":"FASEB J."},{"key":"419_CR11","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1182\/blood.V80.11.2787.2787","volume":"80","author":"M Cattaneo","year":"1992","unstructured":"Cattaneo, M., Lecchi, A., Randi, A., McGregor, J. & Mannucci, P. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood 80, 2787\u20132796 (1992).","journal-title":"Blood"},{"key":"419_CR12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2217\/rme-2018-0133","volume":"14","author":"JW Reinhardt","year":"2019","unstructured":"Reinhardt, J. W. et al. Early natural history of neotissue formation in tissue-engineered vascular grafts in a murine model. Regen. Med. 14, 389\u2013408 (2019).","journal-title":"Regen. Med."},{"key":"419_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2017.04.003","volume":"60\u201361","author":"TH Barker","year":"2017","unstructured":"Barker, T. H. & Engler, A. J. The provisional matrix: setting the stage for tissue repair outcomes. Matrix Biol. 60\u201361, 1\u20134 (2017).","journal-title":"Matrix Biol."},{"key":"419_CR14","doi-asserted-by":"publisher","first-page":"1404846","DOI":"10.3389\/fimmu.2024.1404846","volume":"15","author":"ME Turner","year":"2024","unstructured":"Turner, M. E. et al. The lysosomal trafficking regulator \u2018LYST\u2019: an 80-year traffic jam. Front. Immunol. 15, 1404846 (2024).","journal-title":"Front. Immunol."},{"key":"419_CR15","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1182\/blood.V69.5.1300.1300","volume":"69","author":"M Reddington","year":"1987","unstructured":"Reddington, M. et al. Immature dense granules in platelets from mice with platelet storage pool disease. Blood 69, 1300\u20131306 (1987).","journal-title":"Blood"},{"key":"419_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3181\/00379727-151-39137","volume":"151","author":"JM Holland","year":"1976","unstructured":"Holland, J. M. Serotonin deficiency and prolonged bleeding in beige mice. Proc. Soc. Exp. Biol. Med. Soc.151, 32\u201339 (1976).","journal-title":"Proc. Soc. Exp. Biol. Med. Soc."},{"key":"419_CR17","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/0024-3205(86)90571-0","volume":"38","author":"MG Lampugnani","year":"1986","unstructured":"Lampugnani, M. G., Buczko, W., Ceci, A., Mennini, A. & de Gaetano, G. Normal serotonin uptake by blood platelets and brain synaptosomes but selective impairment of platelet serotonin storage in mice with Chediack-Higashi syndrome. Life Sci. 38, 2193\u20132198 (1986).","journal-title":"Life Sci."},{"key":"419_CR18","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1182\/blood-2012-09-457739","volume":"121","author":"TJ Stalker","year":"2013","unstructured":"Stalker, T. J. et al. Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network. Blood 121, 1875\u20131885 (2013).","journal-title":"Blood"},{"key":"419_CR19","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1111\/jth.12952","volume":"13","author":"M Cattaneo","year":"2015","unstructured":"Cattaneo, M. P2Y12 receptors: structure and function. J. Thromb. Haemost. 13, S10\u2013S16 (2015).","journal-title":"J. Thromb. Haemost."},{"key":"419_CR20","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1161\/01.ATV.0000012805.49079.23","volume":"22","author":"JA Remijn","year":"2002","unstructured":"Remijn, J. A. et al. Role of ADP receptor P2Y(12) in platelet adhesion and thrombus formation in flowing blood. Arterioscler. Thromb. Vasc. Biol. 22, 686\u2013691 (2002).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"419_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3181\/00379727-106-26252","volume":"106","author":"TT Odell","year":"1961","unstructured":"Odell, T. T. & McDONALD, T. P. Life span of mouse blood platelets. Proc. Soc. Exp. Biol. Med.106, 107\u2013108 (1961).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"419_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/(SICI)1096-8652(199709)56:1<17::AID-AJH4>3.0.CO;2-5","volume":"56","author":"GR Baker","year":"1997","unstructured":"Baker, G. R., Sullam, P. M. & Levin, J. A simple, fluorescent method to internally label platelets suitable for physiological measurements. Am. J. Hematol. 56, 17\u201325 (1997).","journal-title":"Am. J. Hematol."},{"key":"419_CR23","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1111\/jth.13397","volume":"14","author":"M Lebois","year":"2016","unstructured":"Lebois, M. et al. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling. J. Thromb. Haemost. JTH 14, 1882\u20131887 (2016).","journal-title":"J. Thromb. Haemost. JTH"},{"key":"419_CR24","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3324\/haematol.2014.122457","volume":"100","author":"CCFMJ Baaten","year":"2015","unstructured":"Baaten, C. C. F. M. J. et al. Gradual increase in thrombogenicity of juvenile platelets formed upon offset of prasugrel medication. Haematologica 100, 1131\u20131138 (2015).","journal-title":"Haematologica"},{"key":"419_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202001094","volume":"9","author":"GJM Mirhaidari","year":"2020","unstructured":"Mirhaidari, G. J. M. et al. Tissue engineered vascular graft recipient interleukin 10 status is critical for preventing thrombosis. Adv. Healthc. Mater. 9, e2001094 (2020).","journal-title":"Adv. Healthc. Mater."},{"key":"419_CR26","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/j.jacc.2012.02.042","volume":"59","author":"MJ Price","year":"2012","unstructured":"Price, M. J. et al. Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trial. J. Am. Coll. Cardiol. 59, 2338\u20132343 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"419_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1538-7836.2011.04364.x","volume":"9","author":"LF Brass","year":"2011","unstructured":"Brass, L. F., Wannemacher, K. M., Ma, P. & Stalker, T. J. Regulating thrombus growth and stability to achieve an optimal response to injury. J. Thromb. Haemost. JTH 9, 66\u201375 (2011).","journal-title":"J. Thromb. Haemost. JTH"},{"key":"419_CR28","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1161\/ATVBAHA.115.306027","volume":"35","author":"S Tara","year":"2015","unstructured":"Tara, S. et al. Cilostazol, Not Aspirin, prevents stenosis of bioresorbable vascular grafts in a venous model. Arterioscler. Thromb. Vasc. Biol. 35, 2003\u20132010 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"419_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000331405","volume":"195","author":"Y Naito","year":"2012","unstructured":"Naito, Y. et al. Characterization of the natural history of extracellular matrix production in tissue-engineered vascular grafts during neovessel formation. Cells Tissues Organs 195, 60\u201372 (2012).","journal-title":"Cells Tissues Organs"},{"key":"419_CR30","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1213\/ANE.0000000000001903","volume":"124","author":"K Jahn","year":"2017","unstructured":"Jahn, K. et al. Effect of Clopidogrel on thrombus formation in an ex vivo parallel plate flow chamber model cannot be reversed by addition of platelet concentrates or vWF concentrate. Anesth. Analg. 124, 1091 (2017).","journal-title":"Anesth. Analg."},{"key":"419_CR31","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.1016\/j.biomaterials.2011.05.078","volume":"32","author":"S Franz","year":"2011","unstructured":"Franz, S., Rammelt, S., Scharnweber, D. & Simon, J. C. Immune responses to implants \u2013 A review of the implications for the design of immunomodulatory biomaterials. Biomaterials 32, 6692\u20136709 (2011).","journal-title":"Biomaterials"},{"key":"419_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.tmrv.2020.09.005","volume":"34","author":"A Maouia","year":"2020","unstructured":"Maouia, A., Rebetz, J., Kapur, R. & Semple, J. W. The immune nature of platelets revisited. Transfus. Med. Rev. 34, 209\u2013220 (2020).","journal-title":"Transfus. Med. Rev."},{"key":"419_CR33","doi-asserted-by":"publisher","first-page":"651740","DOI":"10.3389\/fimmu.2021.651740","volume":"12","author":"PA Borges","year":"2021","unstructured":"Borges, P. A. et al. Adenosine Diphosphate improves wound healing in diabetic mice through P2Y12 receptor activation. Front. Immunol. 12, 651740 (2021).","journal-title":"Front. Immunol."},{"key":"419_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/cmi.2016.56","volume":"15","author":"X Zhang","year":"2018","unstructured":"Zhang, X. et al. Extracellular ADP facilitates monocyte recruitment in bacterial infection via ERK signaling. Cell. Mol. Immunol. 15, 58\u201373 (2018).","journal-title":"Cell. Mol. Immunol."},{"key":"419_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Z Deng","year":"2024","unstructured":"Deng, Z. et al. TGF-\u03b2 signaling in health, disease and therapeutics. Signal Transduct. Target. Ther. 9, 1\u201340 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"419_CR36","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/wound.2012.0406","volume":"2","author":"M Pakyari","year":"2013","unstructured":"Pakyari, M., Farrokhi, A., Maharlooei, M. K. & Ghahary, A. Critical role of transforming growth factor beta in different phases of wound healing. Adv. Wound Care 2, 215 (2013).","journal-title":"Adv. Wound Care"},{"key":"419_CR37","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022210","volume":"10","author":"M-J Goumans","year":"2018","unstructured":"Goumans, M.-J. & Ten Dijke, P. TGF-\u03b2 signaling in control of cardiovascular function. Cold Spring Harb. Perspect. Biol. 10, a022210 (2018).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"419_CR38","doi-asserted-by":"publisher","first-page":"1081376","DOI":"10.3389\/fphys.2022.1081376","volume":"13","author":"F Itoh","year":"2022","unstructured":"Itoh, F. & Watabe, T. TGF-\u03b2 signaling in lymphatic vascular vessel formation and maintenance. Front. Physiol. 13, 1081376 (2022).","journal-title":"Front. Physiol."},{"key":"419_CR39","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1160\/TH17-02-0112","volume":"117","author":"E Sch\u00fctz","year":"2017","unstructured":"Sch\u00fctz, E. et al. Absence of transforming growth factor beta 1 in murine platelets reduces neointima formation without affecting arterial thrombosis. Thromb. Haemost. 117, 1782\u20131797 (2017).","journal-title":"Thromb. Haemost."},{"key":"419_CR40","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.3390\/ijms22094492","volume":"22","author":"K Karolczak","year":"2021","unstructured":"Karolczak, K. & Watala, C. Blood platelets as an important but underrated circulating source of TGF\u03b2. Int. J. Mol. Sci. 22, 4492 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"419_CR41","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1096\/fj.201500179R","volume":"30","author":"YU Lee","year":"2016","unstructured":"Lee, Y. U. et al. TGF-\u03b2 receptor 1 inhibition prevents stenosis of tissue-engineered vascular grafts by reducing host mononuclear phagocyte activation. FASEB J. 30, 2627\u20132636 (2016).","journal-title":"FASEB J."},{"key":"419_CR42","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13578-019-0362-3","volume":"9","author":"A Vall\u00e9e","year":"2019","unstructured":"Vall\u00e9e, A. et al. TGF-\u03b2 in fibrosis by acting as a conductor for contractile properties of myofibroblasts. Cell Biosci. 9, 98\u201398 (2019).","journal-title":"Cell Biosci."},{"key":"419_CR43","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a021873","volume":"8","author":"M Morikawa","year":"2016","unstructured":"Morikawa, M., Derynck, R. & Miyazono, K. TGF-\u03b2 and the TGF-\u03b2 Family: Context-dependent roles in cell and tissue physiology. Cold Spring Harb. Perspect. Biol. 8, a021873 (2016).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"419_CR44","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2217\/rme-2016-0141","volume":"12","author":"E Onwuka","year":"2017","unstructured":"Onwuka, E. et al. The role of myeloid cell-derived PDGF-B in neotissue formation in a tissue-engineered vascular graft. Regen. Med. 12, 249 (2017).","journal-title":"Regen. Med."},{"key":"419_CR45","doi-asserted-by":"publisher","first-page":"952178","DOI":"10.3389\/fcvm.2022.952178","volume":"9","author":"N Poulis","year":"2022","unstructured":"Poulis, N., Martin, M., Hoerstrup, S. P., Emmert, M. Y. & Fioretta, E. S. Macrophage-extracellular matrix interactions: Perspectives for tissue engineered heart valve remodeling. Front. Cardiovasc. Med. 9, 952178 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"419_CR46","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1039\/D2BM01845D","volume":"11","author":"SD Sommerfeld","year":"2023","unstructured":"Sommerfeld, S. D. et al. Biomaterials-based immunomodulation enhances survival of murine vascularized composite allografts. Biomater. Sci. 11, 4022\u20134031 (2023).","journal-title":"Biomater. Sci."},{"key":"419_CR47","doi-asserted-by":"publisher","first-page":"6709","DOI":"10.3390\/ijms24076709","volume":"24","author":"P Entsie","year":"2023","unstructured":"Entsie, P., Kang, Y., Amoafo, E. B., Sch\u00f6neberg, T. & Liverani, E. The signaling pathway of the ADP Receptor P2Y12 in the immune system: recent discoveries and new challenges. Int. J. Mol. Sci. 24, 6709 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"419_CR48","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1172\/JCI17864","volume":"112","author":"P Andre","year":"2003","unstructured":"Andre, P. et al. P2Y12 regulates platelet adhesion\/activation, thrombus growth, and thrombus stability in injured arteries. J. Clin. Invest. 112, 398\u2013406 (2003).","journal-title":"J. Clin. Invest."},{"key":"419_CR49","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/FJC.0000000000000076","volume":"63","author":"HE Speich","year":"2014","unstructured":"Speich, H. E. et al. Signaling via P2Y12 may be critical for early stabilization of platelet aggregates. J. Cardiovasc. Pharmacol. 63, 520 (2014).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"419_CR50","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/35019186","volume":"406","author":"R McKay","year":"2000","unstructured":"McKay, R. Stem cells \u2014 hype and hope. Nature 406, 361\u2013364 (2000).","journal-title":"Nature"},{"key":"419_CR51","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nm0196-90","volume":"2","author":"Y Noishiki","year":"1996","unstructured":"Noishiki, Y., Tomizawa, Y., Yamane, Y. & Matsumoto, A. Autocrine angiogenic vascular prosthesis with bone marrow transplantation. Nat. Med. 2, 90\u201393 (1996).","journal-title":"Nat. Med."},{"key":"419_CR52","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0003-4975(02)03776-1","volume":"75","author":"TE Perry","year":"2003","unstructured":"Perry, T. E. et al. Bone marrow as a cell source for tissue engineering heart valves. Ann. Thorac. Surg. 75, 761\u2013767 (2003).","journal-title":"Ann. Thorac. Surg."},{"key":"419_CR53","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.biomaterials.2007.11.041","volume":"29","author":"JD Roh","year":"2008","unstructured":"Roh, J. D. et al. Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model. Biomaterials 29, 1454\u20131463 (2008).","journal-title":"Biomaterials"},{"key":"419_CR54","first-page":"e2132","volume":"7","author":"JH Im","year":"2017","unstructured":"Im, J. H. & Muschel, R. J. Protocol for Murine\/Mouse platelets isolation and their reintroduction in vivo. Bio-Protoc. 7, e2132 (2017).","journal-title":"Bio-Protoc."}],"container-title":["npj Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41536-025-00419-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41536-025-00419-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41536-025-00419-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T17:00:23Z","timestamp":1757264423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41536-025-00419-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["419"],"URL":"https:\/\/doi.org\/10.1038\/s41536-025-00419-w","relation":{},"ISSN":["2057-3995"],"issn-type":[{"value":"2057-3995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.E.T., B.K., J.W.R., and C.K.B. filed a patent application related to this work. C.K.B. received grant support from Gunze Ltd. C.K.B. and C.A.B., the co-founders of Lyst Therapeutics, LL,C Columbus, OH. None of the work presented in this article was funded by Gunze Ltd or Lyst Therapeutics LLC. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}